These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11598026)

  • 1. Dual role of the Leishmania major ribosomal protein S3a homologue in regulation of T- and B-cell activation.
    Cordeiro-Da-Silva A; Borges MC; Guilvard E; Ouaissi A
    Infect Immun; 2001 Nov; 69(11):6588-96. PubMed ID: 11598026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leishmania cytosolic silent information regulatory protein 2 deacetylase induces murine B-cell differentiation and in vivo production of specific antibodies.
    Silvestre R; Cordeiro-da-Silva A; Tavares J; Sereno D; Ouaissi A
    Immunology; 2006 Dec; 119(4):529-40. PubMed ID: 17026719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Leishmania infantum cytosolic tryparedoxin activates B cells to secrete interleukin-10 and specific immunoglobulin.
    Cabral SM; Silvestre RL; Santarém NM; Tavares JC; Silva AF; Cordeiro-da-Silva A
    Immunology; 2008 Apr; 123(4):555-65. PubMed ID: 18028371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.
    Skeiky YA; Kennedy M; Kaufman D; Borges MM; Guderian JA; Scholler JK; Ovendale PJ; Picha KS; Morrissey PJ; Grabstein KH; Campos-Neto A; Reed SG
    J Immunol; 1998 Dec; 161(11):6171-9. PubMed ID: 9834103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 24,000 MW Trypanosoma cruzi antigen is a B-cell activator.
    Da Silva AC; Espinoza AG; Taibi A; Ouaissi A; Minoprio P
    Immunology; 1998 Jun; 94(2):189-96. PubMed ID: 9741340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunodominant T helper 2 (Th2) response elicited in BALB/c mice by the Leishmania LiP2a and LiP2b acidic ribosomal proteins cannot be reverted by strong Th1 inducers.
    Iborra S; Abánades DR; Parody N; Carrión J; Risueño RM; Pineda MA; Bonay P; Alonso C; Soto M
    Clin Exp Immunol; 2007 Nov; 150(2):375-85. PubMed ID: 17900304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning of a Leishmania major gene encoding for an antigen with extensive homology to ribosomal protein S3a.
    Zemzoumi K; Guilvard E; Sereno D; Preto A; Benlemlih M; Da Silva AC; Lemesre JL; Ouaissi A
    Gene; 1999 Nov; 240(1):57-65. PubMed ID: 10564812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Trypanosoma cruzi alkaline antigen induces polyclonal B-cell activation of normal murine spleen cells by T-cell-independent, BCR-directed stimulation.
    Montes CL; Zuñiga E; Minoprio P; Vottero-Cima E; Gruppi A
    Scand J Immunol; 1999 Aug; 50(2):159-66. PubMed ID: 10447920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the B-cell immune response elicited in BALB/c mice challenged with Neospora caninum tachyzoites.
    Teixeira L; Marques A; Meireles CS; Seabra AR; Rodrigues D; Madureira P; Faustino AM; Silva C; Ribeiro A; Ferreira P; Correia da Costa JM; Canada N; Vilanova M
    Immunology; 2005 Sep; 116(1):38-52. PubMed ID: 16108816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with the Leishmania infantum ribosomal proteins induces protection in BALB/c mice against Leishmania chagasi and Leishmania amazonensis challenge.
    Chávez-Fumagalli MA; Costa MA; Oliveira DM; Ramírez L; Costa LE; Duarte MC; Martins VT; Oliveira JS; Olortegi CC; Bonay P; Alonso C; Tavares CA; Soto M; Coelho EA
    Microbes Infect; 2010 Nov; 12(12-13):967-77. PubMed ID: 20601076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Leishmania infantum acidic ribosomal protein LiP2a induces a prominent humoral response in vivo and stimulates cell proliferation in vitro and interferon-gamma (IFN-gamma) production by murine splenocytes.
    Soto M; Alonso C; Requena JM
    Clin Exp Immunol; 2000 Nov; 122(2):212-8. PubMed ID: 11091277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response.
    Handman E; Symons FM; Baldwin TM; Curtis JM; Scheerlinck JP
    Infect Immun; 1995 Nov; 63(11):4261-7. PubMed ID: 7591056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A lentiviral vaccine expressing KMP11-HASPB fusion protein increases immune response to Leishmania major in BALB/C.
    Mortazavidehkordi N; Fallah A; Abdollahi A; Kia V; Khanahmad H; Najafabadi ZG; Hashemi N; Estiri B; Roudbari Z; Najafi A; Farjadfar A; Hejazi SH
    Parasitol Res; 2018 Jul; 117(7):2265-2273. PubMed ID: 29845415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of monocytes in the up-regulation of the early activation marker CD69 on B and T murine lymphocytes induced by microbial mitogens.
    Vilanova M; Tavares D; Ferreira P; Oliveira L; Nóbrega A; Appelberg R; Arala-Chaves M
    Scand J Immunol; 1996 Feb; 43(2):155-63. PubMed ID: 8633195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Listeria monocytogenes as a short-lived delivery system for the induction of type 1 cell-mediated immunity against the p36/LACK antigen of Leishmania major.
    Soussi N; Milon G; Colle JH; Mougneau E; Glaichenhaus N; Goossens PL
    Infect Immun; 2000 Mar; 68(3):1498-506. PubMed ID: 10678966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions.
    Van den Eertwegh AJ; Noelle RJ; Roy M; Shepherd DM; Aruffo A; Ledbetter JA; Boersma WJ; Claassen E
    J Exp Med; 1993 Nov; 178(5):1555-65. PubMed ID: 7693849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo blocking of L-selectin rescues BALB/c mice from fatal Leishmania major infection.
    Laskay T; Wittmann I; Diefenbach A; Röllinghoff M; Solbach W
    Immunol Lett; 1997 Jun; 57(1-3):89-91. PubMed ID: 9232431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of new Leishmania promastigote surface antigens, LaPSA-38S and LiPSA-50S, as major immunodominant excreted/secreted components of L. amazonensis and L. infantum.
    Bras-Gonçalves R; Petitdidier E; Pagniez J; Veyrier R; Cibrelus P; Cavaleyra M; Maquaire S; Moreaux J; Lemesre JL
    Infect Genet Evol; 2014 Jun; 24():1-14. PubMed ID: 24614507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The levels and patterns of cytokines produced by CD4 T lymphocytes of BALB/c mice infected with Leishmania major by inoculation into the ear dermis depend on the infectiousness and size of the inoculum.
    Lang T; Courret N; Colle JH; Milon G; Antoine JC
    Infect Immun; 2003 May; 71(5):2674-83. PubMed ID: 12704142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-protective effect of a combined L5 plus L3 Leishmania major ribosomal protein based vaccine combined with a Th1 adjuvant in murine cutaneous and visceral leishmaniasis.
    Ramirez L; Corvo L; Duarte MC; Chávez-Fumagalli MA; Valadares DG; Santos DM; de Oliveira CI; Escutia MR; Alonso C; Bonay P; Tavares CA; Coelho EA; Soto M
    Parasit Vectors; 2014 Jan; 7():3. PubMed ID: 24382098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.